FDA Investigator Maria Estrella

Maria Estrella has conducted inspections on 83 sites in 4 countries as of 12 Jun 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
83
Last Inspection Date:
12 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
100003809
Countries of Inspections:
United States of America, India, Canada, Mexico
FDA Investigators that have inspected at least one site in common with Maria Estrella:
Addam S Reynolds, Adetutu M Gidado, Alan L Truong, Alan P Kurtzberg, Alice S Tsao, Amy L Singer, Amy M Codella, Amy M Cramer, Ana P Pineda Zavaleta, Anastasia M Shields, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Anna M Brannen, Anne E Johnson, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Arsen Karapetyan, Ashutosh Rao, PhD, Asia D Clark, Atul J Agrawal, Barbara Jwilimczyk Macri, Byungja E Marciante, Charisse K Green, Constantin Y Philopoulos, Daniel J Grabicki, David A Oluwo, David J Eide, David M Beltran, Dawn L Wydner, Deborah B Nixon, Denise M Digiulio, Denise M Visco, Investigator, Dessa A Antoine, Devon Jenkins, Dhaval H Patel, Donald C Obenhuber, PhD, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Jason R Caballero, Edward O'shaughnessy, Elaine E Gilfillan, Emest F Bizjak, Emily A Baldwin, Emmanuel Jramos Maldonado, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Farhana Khan, Frank J Marciniak, Frederick F Razzaghi, Gayle S Lawson, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Hala L Selby, Helen B Ricalde, Helen Verdel, Hitesh R Patel, Jacob G Lutz, James R Birkenstamm, Jawaid Hamid, Jay B Shah, Jean Blackston Hill, Jean M Kelahan, Jennifer A Bazergui, Jennifer L Custodio, Jennifer L Huntington, Jennifer Macmillan, Jessica M Monteiro, Joan M Cantellops Figueroa, Jogy George, Jolanna A Norton, Jonee J Mearns, Joohi Castelvetere, Jose M Cayuela, Jose Ohernandez Guzman, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Julianne C Mccullough, Justine Tomasso, Kalavati Suvarna, PhD, Karen E D'orazio, Karen L Kosar, Karishma G Gopaul, Keith M Reilly, Kelli F Dobilas, Kendra L Brooks, Kenneth M Gordon, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Kristy E Zuroski, Kyle D Covill, Lakshmi Narasimhan, PhD, Lata C Mathew, PhD, Lauren L Vajo, Li Li, Liatte Kreuger, PharmD, Liming Zhang, Linda F Murphy, Lisa M Bellows, Loretta Nemchik, Luis A Dasta, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Marie F Morin, Marvin D Jones, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael Gurbarg, Michael L Casner, Michael R Klapal, Michael Serrano, Monika Borkowska, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Neal L Adams, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Niketa Patel, Nikki S Ramirez, Nina Yang, Odera I Ekwunife, Pal S Mayasandra, Pankaj H Amin, Parul M Patel, Patricia F Hughes, PhD, Patsy J Domingo, Paul L Bellamy, Paul Mouris, Peter E Baker, Peter R Lenahan, Pratibha Bhat, Qin Xu, Rafael Nevarez Nieves, Ramanda C Gregory, Raymond L Cheung, Regina T Brown, Remache, Reyes Candau Chacon, PhD, Richard E Needham, Richard J Muzeni, Robin P Mathew, Rochelle L Cross, Roger F Zabinski, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Sangeeta M Khurana, PhD, Sarah Adella Fave, Sarah Forney, Sayyem H Akbar, Schultz, Scott T Ballard, Sean G Casey, Sharon K Thoma, PharmD, Sherri J Liu, Sinai I Davis, Sony Mathews, Stacie A Woods, Stelios C Tsinontides, Stephanie T Durso, Stephen J Mottola, Syeda N Mahazabin, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Thomas E Friel, Tonia F Bernard, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Vioela J Caze, Vlada Matusovsky, Wayne J Meyer, William R Chang, William V Millar, Yong Wu, PhD, Yvesna C Blaise, Yvins Dezan, Yvonne C Mcknight, Zachary A Bogorad, Zedong Dong, Zhongren Wu

Maria Estrella's Documents

Publish Date Document Type Title
September, 2011 EIR ISP Sutton Laboratories - EIR, 2011-09-01
October, 2010 FDA 483 PIC Corporation - Form 483, 2010-10-26
June, 2010 FDA 483 Rutherford Chemicals, LLC - Form 483, 2010-06-04
March, 2017 FDA 483 Zydus Lifesciences Limited - Form 483, 2017-03-01
August, 2010 FDA 483 Loricon Testing Service, Inc. - Form 483, 2010-08-12
August, 2013 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2013-08-16
August, 2011 FDA 483 Access Bio, Inc. - Form 483, 2011-09-12
September, 2012 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2012-09-19
January, 2014 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2014-01-08
August, 2013 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2013-08-16
January, 2013 EIR Chromak Research, Inc. - EIR, 2013-01-31
August, 2011 FDA 483 Callahan Chemical Company, Inc. - Form 483, 2011-08-02
June, 2012 FDA 483 VILS Pharma Coating LLC - Form 483, 2012-06-01
October, 2018 FDA 483 ENDO USA, Inc. - Form 483, 2018-12-10
October, 2011 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2011-10-04
January, 2013 FDA 483 Chromak Research, Inc. - Form 483, 2013-01-31
June, 2014 FDA 483 Guest Packaging LLC - Form 483, 2014-06-06
May, 2012 EIR Libra Technical Center, LLC - EIR, 2012-05-11
October, 2012 FDA 483 Pacon Manufacturing Corporation - Form 483, 2012-10-24
December, 2012 EIR Quantex Laboratories Inc. - EIR, 2012-12-28
July, 2011 EIR Camber Pharmaceuticals, Inc. - EIR, 2011-07-20
December, 2022 EIR Interquim, S.A. de C.V. - EIR, 2022-12-16
December, 2022 FDA 483 Bayer de Mexico, S.A. de C.V. - Form 483, 2022-12-09
August, 2019 FDA 483 Hikal Limited - Form 483, 2019-08-02
July, 2010 FDA 483 Cosmax Usa, Corporation - Form 483, 2010-07-19
June, 2012 FDA 483 Rebgro Corporation - Form 483, 2012-06-27
July, 2015 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2015-07-15
August, 2019 FDA 483 Lake Chemicals Private Limited - Form 483, 2019-08-09
December, 2015 EIR HOVIONE LLC - EIR, 2015-12-16
February, 2014 FDA 483 Intergel Pharmaceuticals Inc - Form 483, 2014-02-11
October, 2013 FDA 483 Aurolife Pharma LLC - Form 483, 2013-10-15
May, 2018 EIR Rakshit Drugs Private Ltd - EIR, 2018-05-22
December, 2015 FDA 483 HOVIONE LLC - Form 483, 2015-12-16
October, 2018 FDA 483 Response ENDO USA, Inc. - Form 483R, 2018-11-08
December, 2010 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2010-12-20
October, 2012 EIR Pacon Manufacturing Corporation - EIR, 2012-10-24
April, 2015 FDA 483 Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - Form 483, 2015-04-16
December, 2015 FDA 483 Response HOVIONE LLC - Form 483R, 2015-12-18
December, 2012 FDA 483 L'OREAL USA PRODUCTS, INC. - Form 483, 2012-12-04
August, 2012 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2012-08-21
May, 2012 FDA 483 Libra Technical Center, LLC - Form 483, 2012-05-11
March, 2017 FDA 483 Alkem Laboratories Limited - Form 483, 2017-03-10
June, 2010 FDA 483 Packaging Systems, LLC - Form 483, 2010-06-23

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more